NCT06699498 Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC Status NOT_YET_RECRUITING Phase PHASE2
NCT06694350 Pembrolizumab in Combination with Flutamide Treatment for Recurrence / Metastasis HNSCC Status NOT_YET_RECRUITING Phase PHASE2
NCT06693323 Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC Status RECRUITING Phase PHASE2
NCT06690216 Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors Status ENROLLING_BY_INVITATION Phase PHASE1/PHASE2
NCT06668961 A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06662058 Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation Status RECRUITING Phase NA
NCT06648096 Afatinib in Patients with Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) Status RECRUITING Phase PHASE1/PHASE2
NCT06645808 PET-imaging of Two Vartumabs in Patients With Solid Tumors Status RECRUITING Phase EARLY_PHASE1
NCT06601335 A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Status RECRUITING Phase PHASE3
NCT06597565 A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC Status RECRUITING Phase PHASE2
NCT06578871 Surgery and Reducing Ionizing Radiation of the Unknown Primary Status NOT_YET_RECRUITING Phase PHASE2
NCT06576180 Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Cognitive Function in Patients With Resectable Head and Neck Squamous Cell Carcinoma Status RECRUITING Phase N/A
NCT06575322 Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma Status RECRUITING Phase N/A
NCT06540443 Pilot Study of MPB-2043 Enhanced MRI for Nodal Staging in Head and Neck Squamous Cell Carcinomas Status RECRUITING Phase PHASE1
NCT06532279 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer Status RECRUITING Phase PHASE2
NCT06525220 A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1) Status RECRUITING Phase PHASE3